The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Richard O’Brien, Ulf Andréasson et al.|Alzheimer s & Dementia|2011Cited by 412
CSF biomarker variability in the Alzheimer's Association quality control programNiklas Mattsson, Olivier Bousiges, Ulf Andréasson et al.|Alzheimer s & Dementia|2013Cited by 386
Patients With Alzheimer Disease With Multiple MicrobleedsJeroen D.C. Goos, Wiesje M. van der Flier, Maartje I. Kester et al.|Stroke|2009Cited by 214
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairmentFemke H. Bouwman, Philip Scheltens, Frederik Barkhof et al.|Neurobiology of Aging|2006Cited by 180
Neurofilament ELISA validationAxel Petzold, George P. Paraskevas, Ayşe Altıntaş et al.|Journal of Immunological Methods|2009Cited by 105